Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Thibodaux › NPI 1902465065
Hospital

Thibodaux Regional Health System INC

Thibodaux Regional Health System INC was paid $12.61M by Medicaid between Mar 2019 and Dec 2024, across 167 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.

33Billing provider infoTHIBODAUX REGIONAL HEALTH SYSTEM INC
THIBODAUX, LA 70301
33aNPI1902465065assigned 06/11/2019
33bProvider typeGeneral Acute Care Hospital
28Total paid$12.61M
24GClaims573,934
24DCodes billed167
24AFirst – last monthMar 2019 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Louisiana

Rank by total paid#30 of 96
Median peer was paid$5.17M
This provider vs. median2.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201930,304$464K
202078,427$1.56M
2021105,783$2.22M
2022133,190$3.26M
2023127,784$3.17M
2024incomplete98,446$1.94M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 20% 37,734 33,960 $2.48M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 18% 19,327 17,590 $2.24M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 8.6% 11,533 10,279 $1.09M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6.3% 24,714 22,720 $800K
71045 Radiologic examination, chest; single view 4.1% 14,430 12,958 $522K
74177 Computed tomography, abdomen and pelvis; with contrast material 4.0% 985 916 $502K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 3.5% 20,108 17,970 $437K
80053 Comprehensive metabolic panel 2.6% 50,201 41,228 $333K
70450 Computed tomography, head or brain; without contrast material 2.5% 1,902 1,749 $321K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.5% 1,622 1,488 $312K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2.1% 7,006 6,728 $264K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.1% 53,186 43,894 $259K
155 more codes
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.8% 557 $223K
80050 General health panel 1.7% 6,290 $217K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.7% 9,837 $216K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1.4% 6,221 $182K
36415 Collection of venous blood by venipuncture 1.3% 83,760 $164K
88305 Level IV - Surgical pathology, gross and microscopic examination 1.1% 2,059 $144K
43775 1.1% 421 $139K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.1% 3,656 $133K
83735 1.0% 29,674 $131K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 4,857 $103K
84484 <1% 11,279 $93K
87400 <1% 10,448 $76K
82553 <1% 10,997 $76K
81025 <1% 11,343 $71K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,218 $57K
80061 Lipid panel <1% 5,758 $57K
81001 <1% 24,504 $54K
43281 <1% 85 $53K
82550 <1% 11,449 $50K
87086 Culture, bacterial; quantitative colony count, urine <1% 8,732 $48K
41899 Unlisted procedure, dentoalveolar structures <1% 64 $46K
83690 <1% 8,622 $42K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,303 $37K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,294 $37K
83036 Hemoglobin; glycosylated (A1C) <1% 4,551 $31K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 339 $31K
G0378 Hospital observation service, per hour <1% 473 $25K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 7,496 $24K
84481 <1% 2,582 $22K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,905 $22K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 714 $20K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,361 $19K
88307 <1% 360 $16K
84439 <1% 2,496 $16K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 261 $16K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 39 $16K
88342 <1% 924 $15K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,023 $15K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,227 $14K
82728 <1% 1,808 $14K
71046 Radiologic examination, chest; 2 views <1% 335 $14K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 878 $13K
94761 <1% 953 $12K
83550 <1% 2,122 $12K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 281 $11K
77067 Screening mammography, bilateral, including computer-aided detection <1% 212 $11K
70551 Magnetic resonance imaging, brain; without contrast material <1% 34 $10K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,889 $10K
83540 <1% 2,130 $9K
C1769 Guide wire <1% 115 $8K
99213 Doctor's office visit, returning patient (routine) <1% 283 $8K
84436 <1% 1,769 $8K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 297 $7K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 29 $7K
95811 <1% 13 $7K
58662 <1% 13 $7K
84100 <1% 2,754 $7K
83880 <1% 324 $6K
87420 <1% 486 $6K
84443 Thyroid stimulating hormone (TSH) <1% 569 $5K
96375 Therapeutic injection; each additional sequential IV push <1% 123 $5K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 112 $5K
80048 Basic metabolic panel (calcium, ionized) <1% 1,304 $4K
86140 <1% 1,237 $4K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 97 $4K
73630 <1% 119 $4K
83615 <1% 1,128 $4K
94010 <1% 76 $3K
84479 <1% 827 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 153 $3K
84480 <1% 369 $3K
86160 <1% 286 $3K
94727 <1% 76 $3K
94729 <1% 76 $3K
J2270 Injection, morphine sulfate, up to 10 mg <1% 896 $3K
84153 <1% 170 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 938 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 166 $2K
J3490 Unclassified drugs <1% 1,440 $2K
77063 Screening digital breast tomosynthesis, bilateral <1% 215 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,896 $2K
87653 <1% 65 $2K
J0694 Injection, cefoxitin sodium, 1 gm <1% 626 $2K
81003 <1% 1,347 $2K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 113 $2K
71250 <1% 12 $2K
84425 <1% 101 $2K
95819 <1% 14 $1K
82607 <1% 137 $1K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 237 $1K
80076 <1% 243 $1K
82962 <1% 677 $1K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 67 $1K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,064 $1K
82746 <1% 112 $1K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 12 $1K
72110 <1% 12 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 385 $957.82
82077 <1% 92 $857.82
94664 <1% 99 $833.52
97161 <1% 30 $819.28
84702 <1% 65 $785.30
J2550 Injection, promethazine hcl, up to 50 mg <1% 379 $735.05
95806 <1% 16 $712.16
82565 <1% 214 $709.90
J1644 Injection, heparin sodium, per 1000 units <1% 158 $697.35
76937 <1% 14 $696.68
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 24 $690.15
87040 <1% 59 $671.73
74018 <1% 12 $644.96
A6257 Transparent film, sterile, 16 sq. in. or less, each dressing <1% 420 $598.76
J2704 Injection, propofol, 10 mg <1% 2,883 $581.51
86592 <1% 149 $572.24
83605 <1% 71 $557.11
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 16 $555.91
85651 <1% 218 $552.42
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 154 $547.14
87186 <1% 100 $537.08
96361 Intravenous infusion, hydration; each additional hour <1% 32 $433.54
C9113 Injection, pantoprazole sodium, per vial <1% 209 $398.98
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 255 $383.53
87077 <1% 75 $339.84
73030 <1% 12 $337.00
82950 <1% 65 $282.47
90715 <1% 12 $229.86
83970 <1% 15 $165.12
82652 <1% 14 $164.16
86703 <1% 13 $155.22
84520 <1% 49 $139.36
84550 <1% 75 $126.84
J7050 Infusion, normal saline solution, 250 cc <1% 81 $103.46
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 17 $100.73
86850 <1% 13 $74.54
36000 <1% 32 $64.55
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 246 $61.87
85379 <1% 13 $61.08
J3475 Injection, magnesium sulfate, per 500 mg <1% 12 $57.09
86900 <1% 13 $33.07
86901 <1% 13 $33.07
J7030 Infusion, normal saline solution , 1000 cc <1% 60 $30.90
J7510 Prednisolone oral, per 5 mg <1% 16 $23.85
85610 <1% 14 $9.37
85730 <1% 12 $7.12
J0690 Injection, cefazolin sodium, 500 mg <1% 13 $6.50
A6402 Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing <1% 26 $0.47
90853 Group psychotherapy (other than of a multiple-family group) 0% 2,671 $0.00
02414 0% 109 $0.00
72100 0% 197 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 15 $0.00
Q0243 Injection, casirivimab and imdevimab, 2400 mg 0% 39 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 41 $0.00
90832 Psychotherapy session, about 30 minutes 0% 28 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 0% 18 $0.00
G0463 Hospital outpatient clinic visit for assessment and management of a patient 0% 983 $0.00
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml 0% 104 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGIARDINA, JACOB (CHAIRMAN)
Same official

Other billing entities under GIARDINA, JACOB

Full network →
ProviderLocationPaid
Thibodaux Regional Health System INCThibodaux, LA$231K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.